Glaxosmithkline Intellectual Property (No.5) Limited is a liquidation company incorporated on 23 April 2019 with the registered office located in Liverpool, Merseyside. Glaxosmithkline Intellectual Property (No.5) Limited was registered 6 years ago.
Registered office address changed from Gsk Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NY United Kingdom to C/O Bdo Llp 5 Temple Square Temple Street Liverpool L2 5RH on 22 July 2025
Submitted on 22 Jul 2025
Statement of capital on 3 June 2025
Submitted on 3 Jun 2025
Statement by Directors
Submitted on 3 Jun 2025
Solvency Statement dated 21/05/25
Submitted on 2 Jun 2025
Resolutions
Submitted on 2 Jun 2025
Termination of appointment of Jemma-Louise Reynolds as a director on 31 March 2025
Submitted on 7 Apr 2025
Statement of capital following an allotment of shares on 1 April 2025